Advertisement
Advertisement
Entera Bio’s Promising Phase 3 Study and Market Potential Drive Buy Rating
PremiumRatingsEntera Bio’s Promising Phase 3 Study and Market Potential Drive Buy Rating
3M ago
Entera Bio Reports Q2 2025 Financial Results and Strategic Progress
Premium
Company Announcements
Entera Bio Reports Q2 2025 Financial Results and Strategic Progress
3M ago
Entera Bio Reports Q2 2025 Financial Results
Premium
Company Announcements
Entera Bio Reports Q2 2025 Financial Results
3M ago
Entera Bio, Opko Health announce new in vivo data for OPK-88006
PremiumThe FlyEntera Bio, Opko Health announce new in vivo data for OPK-88006
5M ago
Opko Health, Entera Bio say OPK-88006 data selected for ENDO 2025
Premium
The Fly
Opko Health, Entera Bio say OPK-88006 data selected for ENDO 2025
5M ago
Entera Bio files $100M mixed securities shelf
Premium
The Fly
Entera Bio files $100M mixed securities shelf
6M ago
Entera Bio Announces 2024 Financial Results and Updates
PremiumCompany AnnouncementsEntera Bio Announces 2024 Financial Results and Updates
8M ago
Entera Bio (ENTX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Entera Bio (ENTX) Q4 Earnings Cheat Sheet
8M ago
Entera Bio’s Strategic Partnership and Positive Developments Drive Buy Rating
Premium
Ratings
Entera Bio’s Strategic Partnership and Positive Developments Drive Buy Rating
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100